Roche Holding AG (RHHVF)
The price, the headline numbers and the latest news, in one place.
Roche Holding AG (RHHVF) Stock Price, Analysis & Data
| Bid | 431.45 |
| Market Cap | 352B |
| Revenue (ttm) | 63B |
| Net Income (ttm) | 12.3B |
| 0.35 | |
| 18.84 | |
| 23.47 | |
| 16.89 | |
| P/B (ttm) | 8.76 |
| P/S (ttm) | 5.60 |
| Earnings Date | Jan 28, 2027 |
| Ask | 452.89 |
| Volume | 523 |
| Avg. Volume (20D) | 4,917 |
| Open | 439.32 |
| Previous Close | 443.25 |
| Day's Range | 439.15 - 441.86 |
| 52-Week Range | 314.15 - 490.33 |
| Analyst | Strong<br>Buy |
| Price Target | 512.87 (15.99%) |
| Dividends | $12.40 (2.81%) |
| Ex-Dividend Date | Mar 12, 2026 |
About RHHVF
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haematology, infectious diseases, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for ...
Financial Performance
In 2025, Roche's revenue was 63.36B, an increase of 1.54% compared to the previous year's 62.4B. Earnings were 12.88B, an increase of 55.61%.
Financial StatementsAnalyst Forecast
According to 1 analyst ratings, the average rating for RHHVF stock is "Strong Buy". The 12-month stock price forecast is 512.87, which is upside of 15.99% from the latest price.
Stock ForecastsEarnings Surprise
- Revenue of n/a misses estimates by $0, with NaN% YoY growth.
- EPS of misses estimates by , with NaN% YoY growth.
Analysts project revenue of ... Upgrade
